Tevogen (TVGN) Non Operating Interest Expenses (2023 - 2025)

Tevogen (TVGN) has reported Non Operating Interest Expenses for 3 consecutive years, with $24571.0 the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Non Operating Interest Expenses fell 84.23% year-over-year to $24571.0; the trailing twelve-month figure through Mar 2025 stood at $208614.0 (down 80.36% YoY), and the FY2024 full-year result was $184037.0, down 84.74% from the prior year.
• Non Operating Interest Expenses grew to $24571.0 in Q1 2025 per TVGN's latest filing, from $15798.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $317525.0 in Q4 2023 and bottomed at $12459.0 in Q3 2024.
• Historically, Non Operating Interest Expenses has averaged $159297.0 across 3 years, with a median of $155786.0 in 2024.
• The widest YoY moves for Non Operating Interest Expenses: up 46.09% in 2024, down 95.85% in 2024.
• Over 3 years, Non Operating Interest Expenses stood at $317525.0 in 2023, then tumbled by 95.02% to $15798.0 in 2024, then soared by 55.53% to $24571.0 in 2025.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $24571.0, $15798.0, and $12459.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.